Published on 3 Nov 2024 on Los Angeles Times
Irvine-headquartered Edwards Lifesciences has successfully completed the sale of its Critical Care product group to BD (Becton, Dickinson and Company)...
Start tracking your investments with Statfolio
Free Report) released its fiscal 2024 fourth-quarter financial report after the closing bell, wit...
Steris PLC's strategic acquisitions, such as the purchase of surgical instrumentation assets from...
On Thursday, Becton, Dickinson and Company (NYSE:BDX) reported fourth-quarter sales of $5.44...
BD's overall topline in the fourth quarter of fiscal 2024 benefits from revenue growth in all...
Free Report) , popularly known as BD, is scheduled to report fourth-quarter fiscal 2024 results o...
Free Report) is scheduled to report second-quarter fiscal 2025 results on Nov. 6, after market...
Irvine-headquartered Edwards Lifesciences has successfully completed the sale of its Critical Car...
We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this...
We recently made a list of Goldman Sachs’ List Of Stocks Popular With Mutual Fund Managers: Top 2...